Literature DB >> 14659695

The intracellular voyage of cholera toxin: going retro.

Wayne I Lencer1, Billy Tsai.   

Abstract

Cholera toxin (CT) and related AB(5)-subunit toxins move from the plasma membrane through the trans-Golgi and endoplasmic reticulum (ER) to the cytosol of host cells. The toxins exploit a specific glycolipid pathway rather than a protein pathway. They bind glycolipids that associate with lipid rafts at the cell surface, which carry the toxins retrograde to the Golgi and ER. In the ER, the A1-chain of the CT unfolds and enters the cytosol by hijacking the cellular machinery that enables misfolded proteins to cross the membrane for degradation by the proteasome, a process termed retro-translocation. Upon entering the cytosol, the A1-chain rapidly refolds, avoids the proteasome and induces toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659695     DOI: 10.1016/j.tibs.2003.10.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  88 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

2.  Retrograde transport of cholera toxin from the plasma membrane to the endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in Exo2-treated cells.

Authors:  Yan Feng; Ashutosh P Jadhav; Chiara Rodighiero; Yukako Fujinaga; Tomas Kirchhausen; Wayne I Lencer
Journal:  EMBO Rep       Date:  2004-05-21       Impact factor: 8.807

Review 3.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

4.  Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not Derlin-1 or -2.

Authors:  David E Saslowsky; Jin Ah Cho; Himani Chinnapen; Ramiro H Massol; Daniel J-F Chinnapen; Jessica S Wagner; Heidi E De Luca; Wendy Kam; Barry H Paw; Wayne I Lencer
Journal:  J Clin Invest       Date:  2010-12       Impact factor: 14.808

5.  Fucosylation and protein glycosylation create functional receptors for cholera toxin.

Authors:  Amberlyn M Wands; Akiko Fujita; Janet E McCombs; Jakob Cervin; Benjamin Dedic; Andrea C Rodriguez; Nicole Nischan; Michelle R Bond; Marcel Mettlen; David C Trudgian; Andrew Lemoff; Marianne Quiding-Järbrink; Bengt Gustavsson; Catharina Steentoft; Henrik Clausen; Hamid Mirzaei; Susann Teneberg; Ulf Yrlid; Jennifer J Kohler
Journal:  Elife       Date:  2015-10-29       Impact factor: 8.140

6.  Activity-dependent NMDA receptor degradation mediated by retrotranslocation and ubiquitination.

Authors:  Akihiko Kato; Nathalie Rouach; Roger A Nicoll; David S Bredt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

7.  Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue.

Authors:  Kara B Bowen; Aaron P Reimers; Sarah Luman; Joseph D Kronz; William E Fyffe; Julia Thom Oxford
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

8.  Conformational instability of the cholera toxin A1 polypeptide.

Authors:  Abhay H Pande; Patricia Scaglione; Michael Taylor; Kathleen N Nemec; Summer Tuthill; David Moe; Randall K Holmes; Suren A Tatulian; Ken Teter
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

9.  Gas phase characterization of the noncovalent quaternary structure of cholera toxin and the cholera toxin B subunit pentamer.

Authors:  Jonathan P Williams; Daniel C Smith; Brian N Green; Brian D Marsden; Keith R Jennings; Lynne M Roberts; James H Scrivens
Journal:  Biophys J       Date:  2006-02-03       Impact factor: 4.033

10.  Hydrocortisone modulates cholera toxin endocytosis by regulating immature enterocyte plasma membrane phospholipids.

Authors:  Lei Lu; Yuanwu Bao; Abdullah Khan; Allan M Goldstein; David S Newburg; Andrea Quaroni; Dennis Brown; W Allan Walker
Journal:  Gastroenterology       Date:  2008-03-22       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.